A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®

Clinical trial NCT05405725 · COMPLETED

Trial details

NCT number: NCT05405725
Sponsor: Enzene Biosciences Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Postmenopausal Osteoporosis

Start date: 2022-07-04
Primary completion: 2024-07-18
Enrollment: 504

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.